A new BDNF inducer enters the pipeline.
Drugs in the Queue
Here's an overview of some of the more promising potential treatments moving through the research pipeline.
An ampakine, a modulator of glutamate receptors, reduced memory and learning problems in HD mice.
Drugs that increase the activity of PPAR-delta are added to the pipeline of potential treatments.